ArticleTherapeutic advances in medical oncology2023

Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer.

Rui Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.